Evaluation of the Safety, Tolerability, and Pharmacokinetics of PLN-74809 in Participants With Acute Respiratory Distress Syndrome (ARDS) Associated With at Least Severe COVID-19
Clinical trial NCT04565249 · TERMINATED
Trial details
- NCT number
- NCT04565249
- Sponsor
- Pliant Therapeutics, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-22
- Primary completion
- 2021-06-01
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.